Careprost Eye Drops

Careprost Eye Drops (Generic Bimatoprost Ophthalmic Solution) - Product Information

Careprost Eye Drops (Generic Bimatoprost Ophthalmic Solution) is indicated as monotherapy for the reduction of elevated intraocular pressure (IOP) in patients with chronic glaucoma or ocular hypertension; or as adjunctive therapy in patients not adequately controlled on other agents.
Bimatoprost ophthalmic solution, 0.03% is also indicated to treat hypotrichosis of the eyelashes by increasing their growth including length, thickness and darkness.
We also have in stock Latanoprost Eye Drops (Latoprost RT Ophthalmic Solution) which is used to treat used for the treatment of high blood pressure in the eyes, a medical condition termed as elevated intraocular pressure which is characteristic of patients diagnosed with open-angle glaucoma or ocular hypertension.

Name of the Drug

Careprost Ophthalmic Solution.

Manufacturer of Careprost Eye Drops

Sun Pharmaceutical Industries Limited, India  
Website: sunpharma.com

Active Pharmaceutical Ingredient

The active ingredient present in Careprost Ophthalmic Solution is Bimatoprost. Each mL contains 0.3 mg Bimatoprost.

Uses of Careprost Eye Drops

Careprost ophthalmic solution (Bimatoprost eye drops) is used to treat certain diseases of the eye like open-angle glaucoma and ocular (eye) hypertension which occurs in many people as they grow older. Glaucoma is caused by high pressure in your eye and can lead to pain from pressure in your eye and then can eventually harm your vision. This medicine can help you keep your sight by reducing the pressure in your eye and stopping eye pain.
Bimatoprost ophthalmic (eye) solution is also used to treat eyelash hypotrichosis (not enough eyelashes) by increasing their growth and making the eyelashes longer, thicker, and darker.

Careprost Eye Drops - Dosage

Generic Bimatoprost ophthalmic solution should be administered exactly as suggested by your doctor. Your doctor may recommend a dosage of Careprost eye drops depending on your age, medical requirement, body weight, other medical conditions, and current medications. Ensure the face is clean, makeup and contact lenses are removed.
Reduction Of Elevated Intraocular Pressure:
One drop in the affected eye(s) once daily in the evening. Reduction of the intraocular pressure starts approximately 4 hours after the first administration with maximum effect reached within approximately 8 to 12 hours.
Eyelash Hypotrichosis:
Once nightly, place one drop of bimatoprost ophthalmic solution, 0.03% on the disposable sterile applicator supplied with the package and apply evenly along the skin of the upper eyelid margin at the base of the eyelashes. The upper lid margin in the area of lash growth should feel lightly moist without runoff. Blot any excess solution runoff outside the upper eyelid margin with a tissue or other absorbent cloth. Dispose of the applicator after one use. Repeat for the opposite eyelid margin using a new sterile applicator.
Careprost eye drops work effectively if the amount of Bimatoprost is maintained at a constant level in the body. You should be systematic about the daily schedule for the medication such that you administer Bimatoprost ophthalmic solution at about the same time every day, to get the maximum benefit of the medication. Continue using Careprost eye drops without missing any doses for the recommended treatment period and do not stop the treatment suddenly even if you feel better.

Please consult your doctor for exact dosing instructions. Careprost eye drops (Generic Bimatoprost ophthalmic solution) should be administered in the dose prescribed by the doctor and for the duration recommended by the doctor.

Missed Dose

If you forget to take your regular Careprost Eye Drops dose on time, take it whenever you remember.
If you remember the next day, skip the missed dose and take your scheduled dose. Do not take a double dose to compensate the missed dose.

Careprost Eye Drops Mechanism of Action

Bimatoprost is a structural prostaglandin analog.
Bimatoprost Ophthalmic Solution is recommended as therapy to ease the pressure in the inner region of the eyes, also known as intraocular pressure. Bimatoprost Ophthalmic Solution is also favorable for enhancing the growth of eyelashes. The exact mechanism of action of Bimatoprost Ophthalmic Solution is unidentified.
Bimatoprost may lessen the pressure in the eye by intensifying the rate of fluid drainage from the eye of patients diagnosed with narrow angle glaucoma.
Existence of excessive fluids in the eye may lead to hazardous medical conditions such as optic nerve damage and loss of vision.Although the precise mechanism of action is unknown, the growth of eyelashes is believed to occur by increasing the percent of hairs in, and the duration of the anagen or growth phase.

Storage Instructions for Careprost Eye Drops (Generic Bimatoprost Ophthalmic Solution)

Store Careprost Eye Drops at controlled room temperature (20°C to 25°C),protected from heat, moisture, and sunlight. Excursions are permitted from 15°C to 30°C.
Retain the original packing of the medication and do not consume past its expiration date printed on the blister pack. Keep the pack of Careprost Eye Drops away from the reach of children and pets. Do not dispose Careprost Eye Drops (Generic Bimatoprost Ophthalmic Solution) along with domestic waste or sewage. Consult your doctor or pharmacist about the correct method of disposal.

Contraindications

Careprost Eye Drops are contraindicated in patients with a hypersensitivity to Bimatoprost or any inactive ingredient present in Careprost Ophthalmic Solution.

Overdose

No information is available on overdosage in humans. If overdose with Careprost Eye drops 0.03% (Bimatoprost Ophthalmic Solution) occurs, treatment should be symptomatic.
In oral (by gavage) mouse and rat studies, doses up to 100 mg/kg/day did not produce any toxicity. This dose expressed as mg/m2 is at least 70 times higher than the accidental dose of one bottle of Bimatoprost Ophthalmic Solution 0.03% for a 10 kg child.

Warnings and Precautions

Pigmentation:
Bimatoprost ophthalmic solution has been reported to cause changes to pigmented tissues. The most frequently reported changes have been increased pigmentation of the iris, periorbital tissue (eyelid) and eyelashes. Pigmentation is expected to increase as long as bimatoprost is administered. After discontinuation of bimatoprost, pigmentation of the iris is likely to be permanent, while pigmentation of the periorbital tissue and eyelash changes have been reported to be reversible in some patients.
Eyelash Changes:
Bimatoprost ophthalmic solution may gradually change eyelashes and vellus hair in the treated eye. These changes include increased length, thickness, and number of lashes. Eyelash changes are usually reversible upon discontinuation of treatment.
Intraocular Inflammation:
Prostaglandin analogs, including bimatoprost, have been reported to cause intraocular inflammation. In addition, because these products may exacerbate inflammation, caution should be used in patients with active intraocular inflammation (e.g., uveitis).
Macular Edema
Macular edema, including cystoid macular edema, has been reported during treatment with bimatoprost ophthalmic solution. Bimatoprost 0.03% ophthalmic solution should be used with caution in aphakic patients, in pseudophakic patients with a torn posterior lens capsule, or in patients with known risk factors for macular edema.
Bacterial Keratitis:
There have been reports of bacterial keratitis associated with the use of multiple-dose containers of topical ophthalmic products.
Contact Lens Use
Careprost 0.03% ophthalmic solution contains benzalkonium chloride, which may be absorbed by and cause discoloration of soft contact lenses. Contact lenses should be removed prior to instillation of Careprost and may be reinserted 15 minutes following its administration.

Side Effects of Bimatoprost Ophthalmic Solution

In a 12-month clinical study With Bimatoprost Ophthalmic Solution 0.01%, the most common adverse reaction was conjunctival hyperemia (31%). Approximately 1.6% of patients discontinued therapy due to conjunctival hyperemia. Other side effects reported in 1 to 4% of patients with Bimatoprost ophthalmic solution 0.01% in this study included conjunctival edema, conjunctival hemorrhage, eye irritation, eye pain, eye pruritus, erythema of eyelid, eyelids pruritus, growth of eyelashes, hypertrichosis, instillation site irritation, punctate keratitis, skin hyperpigmentation, vision blurred, and visual acuity reduced.
Post marketing side effects reported include the following: include: asthma-like symptoms, dizziness, dry eye, dyspnea, eye discharge, eye edema, foreign body sensation, headache, hypersensitivity including signs and symptoms of eye allergy and allergic dermatitis, hypertension, lacrimation increased, periorbital and lid changes associated with periorbital fat atrophy leading to skin tightness, deepening of the eyelid sulcus, eyelid ptosis, enophthalmos, and eyelid retraction; and photophobia.

Bimatoprost Ophthalmic Solution During Pregnancy

Bimatoprost Ophthalmic Solution (Careprost Eye drops 0.03%) has been classified by the US FDA as Pregnancy Category C.
There are no adequate and well-controlled studies of Bimatoprost ophthalmic solution administration in pregnant women. The administration of Bimatoprost Eye drops during pregnancy is not known to cause any increase in the risk of major birth defects or miscarriages based on Bimatoprost postmarketing experience.
In embryofetal developmental studies, administration of bimatoprost to pregnant mice and rats during organogenesis, resulted in abortion and early delivery at oral doses at least 33 times (mice) or 94 times (rats) the human exposure to Bimatoprost 0.03% dosed bilaterally once daily.
Because animal reproductive studies are not always predictive of human response Careprost Eye drops 0.03% should be administered during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Do not use this medicine without your doctor's consent in case you are pregnant. Stop using this medication and inform your doctor immediately if you become pregnant during treatment.
It is not known if Bimatoprost is transmitted through breastmilk and if it harms the nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby. Pregnant women and nursing mothers should consult their doctor before using Bimatoprost Eye drops for the treatment of their medical condition.

Buy Generic Bimatoprost Ophthalmic Solution Online From Only $26.49 per 3 ml Bottle

You can buy Generic Bimatoprost ophthalmic solution 0.03% online from Everest Online Pharmacy at a cheap price. Careprost Eye Drops in strength of 0.03% of Bimatoprost, manufactured by Sun Pharmaceutical Industries Limited, India, are supplied in a bottle of 3 ml eye drops. The 3 ml bottle cost only $26.49 per unit when you place an order for 10 bottles.

Disclaimer

The above information is provided to the best of our knowledge and in good faith. It is without a warrant of any kind, expressed or implied.

Shipping Restriction